The technology integrates the genetic information of the patients thanks to the use of artifiial intelligence tools that allow to create predictive profiles. It was 12 years of hard scientific and clinical studies of researchers at the Molecular Clinical Biomedicine Technologycal Consortium of the Catholic University (BRMC) to create a genetic test call ThyroidPrint, which determines wheter a nodule lodge in the thyroid of a patient is cancerous or not.